OneWater Marine remains a 'Hold' as it shifts from serial acquisition to deleveraging and slow premiumization, improving its balance sheet and margins. ONEW's Q1 revenue from new boats fell 12%, but higher-priced yacht sales and improved used boat margins lifted gross margin to 23.8%, a two-year high. The $50 million Ocean Bio-Chem sale and disciplined FCF deployment reduced net LT debt/EBITDA to ~4.1x, below the 4.5x target.









